Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BATM Advanced CommunicationsLSE:BVC -0.84%33 Days Sales Outstanding is 98.82 as of Jun. 2026, which is 34% above its 10-year median of 73.71. GuruFocus rates LSE:BVC with a GF Score™ of 33/100 and a GF Value™ of £0.15 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 809 Medical Devices & Instruments companies, BATM Advanced Communications ranks worse than 76.02% on this metric.
The historical rank and industry rank for BATM Advanced Communications's Days Sales Outstanding or its related term are showing as below:
LSE:BVC'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.53 Med: 73.71 Max: 93.57
Current: 93.57
During the past 13 years, BATM Advanced Communications's highest Days Sales Outstanding was 93.57. The lowest was 54.53. And the median was 73.71.
LSE:BVC's Days Sales Outstanding is ranked worse than 76.02% of 809
companies
in the Medical Devices & Instruments industry
Industry Median: 65.38
vs LSE:BVC: 93.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BATM Advanced Communications Days Sales Outstanding Chart
LSE:BVC vs ISRG, BDX, RMD: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's Days Sales Outstanding falls into.
BATM Advanced Communications Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BATM Advanced Communications (LSE:BVC) has a Days Sales Outstanding of 98.82 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on BATM Advanced Communications and its competitors. This is 34% above median its historical median of 73.71. Over the past decade, BATM Advanced Communications' Days Sales Outstanding has ranged from 54.53 to 93.57. According to the industry distribution chart, BATM Advanced Communications ranks #615 out of 809 companies in the Medical Devices & Instruments industry, placing it in the top 76%.
Is BATM Advanced Communications' Days Sales Outstanding too high?
BATM Advanced Communications' current Days Sales Outstanding of 98.82 is 34% above median its 10-year median of 73.71. Over the past 10 years, this metric has ranged from a low of 54.53 to a high of 93.57. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. BATM Advanced Communications' value of 98.82 is 51.1% above this industry median. Based on the distribution chart, BATM Advanced Communications ranks #615 out of 809 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, BATM Advanced Communications has a GF Score™ of 33/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' Days Sales Outstanding compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BATM Advanced Communications ranks #615 out of 809 companies for Days Sales Outstanding. This places BATM Advanced Communications in the lower half of its industry. The industry median Days Sales Outstanding is 65.38. BATM Advanced Communications' value of 98.82 is 51.1% above this benchmark. Historically, BATM Advanced Communications' own Days Sales Outstanding has ranged from 54.53 to 93.57 over the past decade. While the company's 10-year median is 73.71 vs. the industry median of 65.38, BATM Advanced Communications has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BATM Advanced Communications's current Days Sales Outstanding of 98.82 is 51.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on BATM Advanced Communications and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BATM Advanced Communications's current Days Sales Outstanding is 98.82, which is 34% above median its own 10-year median of 73.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
Based on GuruFocus' analysis, BATM Advanced Communications (LSE:BVC) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.15, compared to a current price of £0.12 — trading 21.7% below its estimated fair value. The current Days Sales Outstanding is 98.82, which is 34% above median its 10-year median of 73.71 and 51.1% above the Medical Devices & Instruments industry median of 65.38. BATM Advanced Communications' overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For BATM Advanced Communications (LSE:BVC), the current Days Sales Outstanding is 98.82 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BATM Advanced Communications (LSE:BVC) Overvalued in 2026?
Based on GuruFocus' analysis, BATM Advanced Communications stock appears to be undervalued.
The current stock price of £0.12 is trading 21.7% below its estimated GF Value™ of £0.15.
GuruFocus considers BATM Advanced Communications to be Modestly Undervalued.
Key valuation signals for LSE:BVC:
Days Sales Outstanding: 98.82 (34% above median its 10-year median of 73.71)
GF Value™: £0.15 vs. price of £0.12 (21.7% below fair value)
Industry Position: 51.1% above the Medical Devices & Instruments median (#615 of 809)
No single metric tells the full story. See the LSE:BVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
33GF Score
Get the complete analysis for LSE:BVC
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BVC has been successfully added to your 
